All Disease Treatment & Prevention articles – Page 3
-
NewsGut microbiota: implications in pathogenesis and potential therapeutic target in primary biliary cholangitis
A new review synthesizes current evidence on gut microbiota dysbiosis in PBC, elucidates its pathogenic mechanisms, and explores its potential as both a diagnostic biomarker and a novel therapeutic target.
-
NewsLow-dose cannabis compound reduces side effects of HIV treatment
Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART). Benefits included increased production of serotonin, while inflammation, cholesterol and harmful secondary bile acids were all reduced.
-
NewsThe ‘MDME Axis’: A new view on how microbial metabolites epigenetically shape host health
A review introduces the ’MDME Axis’, a new framework explaining how metabolites from the gut microbiome epigenetically reprogram our genes, influencing host health and disease.
-
NewsTemporary benefit for immune system in early HIV treatment, but dysregulation returns
A study investigated whether immune dysregulation can be prevented by starting HIV medication immediately after infection. Six months after this early treatment, the immune system did indeed work as in people without HIV, but in the longer term, the immune system was disrupted again.
-
NewsAncient viral DNA shapes modern human placentas
Researchers have uncovered how ancient viral DNA controls a gene linked to placenta development and pre-eclampsia, a life-threatening pregnancy disorder. The research could help identify pre-eclampsia risk much earlier.
-
NewsAccessible imaging technique can predict cardiac risks in patients with Chagas disease
A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for predicting the risk of cardiac complications in patients with chronic Chagas disease.
-
NewsNew insights on gut microbes that prevent formation of cancer-causing compounds
Gut microbes metabolize dietary nitrates and nitrites and prevent the formation of cancer-causing compounds called nitrosamines. New research sheds light on these processes and pinpoints which types of bacteria are most important.
-
NewsResearch finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
A whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after having the vaccine — and the risks after infection lasted much longer.
-
News‘Rotten egg’ gas could be the answer to treating nail infections, say scientists
Hydrogen sulphide, the volcanic gas that smells of rotten eggs, could be used in a new treatment for tricky nail infections that acts faster but with fewer side effects, according to scientists.
-
NewsStudy reveals critical impact of universal cCMV screening on early detection of hearing loss in newborns
A comprehensive eight-year study reveals that approximately one-third of congenital cytomegalovirus-related hearing loss develops after the newborn period—cases that would be missed without universal screening programs.
-
NewsNew editorial urges clinicians to address sex-based disparities in sepsis treatment
Standardized antibiotic dosing frequently ignores patient-level variability. A newly published editorial is calling attention to how biological sex and gender inequities contribute to suboptimal sepsis treatment, potentially compromising outcomes for women.
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsScientists develop novel gene therapy for hereditary hearing loss
Scientists have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. The treatment holds promise for treating a wide range of mutations that cause hearing loss.
-
NewsRebalancing the gut: how AI solved a 25-year Crohn’s disease mystery
Researchers have settled a decades-long debate surrounding the role of the first Crohn’s disease gene to be associated with a heightened risk for developing the auto-immune condition.
-
NewsGroundbreaking new projects launched to lower the cost of monoclonal antibody production
LifeArc and the Gates Foundation have awarded more than $5m to seven projects aimed at developing cheaper and more efficient ways to produce monoclonal antibody (mAb) treatments. The innovative approaches include using filamentous fungus to produce mAbs.
-
NewsReview explores roles, mechanisms and applications of intra-tumoral microbiota in cancers
A recent review provides an overview of the hallmarks, roles, molecular mechanisms, and clinical applications of intra-tumoral microbiota in multiple human cancers.
-
NewsStudy links multiple sclerosis with distinct oral microbiome
Researchers have produced the most comprehensive genetic and metabolic analysis to date of the oral microbiome associated with multiple sclerosis (MS). They found that people with MS have a distinct oral microbiome compared to healthy individuals.
-
NewsNew role of gut bacteria provides hope for a novel IBS treatment
Research clarifies the complex interaction between gut bacteria and IBS, identifying two bacteria that together can produce serotonin: Limosilactobacillus mucosae and Ligilactobacillus ruminis.
-
NewsHow to hack your microbiome for lifelong health
A new book, The Microbiome Master Key, dissects the latest microbiome research, dispels common myths and provides simple, science-backed tips on how to leverage your microbiome to promote healthy living and aging.
-
NewsIn a nasal spray, gold nanoparticles deliver a targeted treatment to the brain
In the form of a ‘nasal spray’, tiny gold particles act as carriers, delivering a treatment directly to the brain: a new nanotechnological device for the treatment and prevention of neuropsychiatric and neurodegenerative diseases and infections.